University of Minnesota. Driven to Discover.
A total of 62.4% of patients taking tafenoquine were free of P vivax after 6 months.
The outbreak has reached 422 cases, and 74 suspected Ebola infections are under investigation.
Alongside the finding that progress has stalled in hard-hit countries, the WHO and partners launch a new response strategy.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.